PFKFB3 and breast cancer: tRiMetF31 abundance is decreased in BC, and knockdown of tRiMetF31 expression restores PFKFB3-driven angiogenesis, suggesting that tRiMetF31 may act as a potential target for the diagnosis and prognosis of BC.